These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22748801)

  • 1. Improving known classes of antibiotics: an optimistic approach for the future.
    Bush K
    Curr Opin Pharmacol; 2012 Oct; 12(5):527-34. PubMed ID: 22748801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New antibacterial agents on the market and in the pipeline].
    Kern WV
    Internist (Berl); 2015 Nov; 56(11):1255-63. PubMed ID: 26475603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New β-lactam-β-lactamase inhibitor combinations in clinical development.
    Shlaes DM
    Ann N Y Acad Sci; 2013 Jan; 1277():105-14. PubMed ID: 23346860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New antibiotics - standstill or progress].
    Rademacher J; Welte T
    Med Klin Intensivmed Notfmed; 2017 Apr; 112(3):206-213. PubMed ID: 28314920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotics in development targeting protein synthesis.
    Sutcliffe JA
    Ann N Y Acad Sci; 2011 Dec; 1241():122-52. PubMed ID: 22191530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoring methicillin-resistant Staphylococcus aureus susceptibility to β-lactam antibiotics.
    Tan CM; Therien AG; Lu J; Lee SH; Caron A; Gill CJ; Lebeau-Jacob C; Benton-Perdomo L; Monteiro JM; Pereira PM; Elsen NL; Wu J; Deschamps K; Petcu M; Wong S; Daigneault E; Kramer S; Liang L; Maxwell E; Claveau D; Vaillancourt J; Skorey K; Tam J; Wang H; Meredith TC; Sillaots S; Wang-Jarantow L; Ramtohul Y; Langlois E; Landry F; Reid JC; Parthasarathy G; Sharma S; Baryshnikova A; Lumb KJ; Pinho MG; Soisson SM; Roemer T
    Sci Transl Med; 2012 Mar; 4(126):126ra35. PubMed ID: 22440737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New antibiotics in infection treatment].
    Płusa T
    Pol Merkur Lekarski; 2018 Dec; 45(270):213-219. PubMed ID: 30693905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent developments in antibiotic agents for the treatment of complicated intra-abdominal infections.
    Lin SY; Huang CH; Ko WC; Chen YH; Hsueh PR
    Expert Opin Pharmacother; 2016; 17(3):339-54. PubMed ID: 26610040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of new antibiotics: taking off finally?
    Bettiol E; Harbarth S
    Swiss Med Wkly; 2015; 145():w14167. PubMed ID: 26230280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging drugs for nosocomial pneumonia.
    Liapikou A; Torres A
    Expert Opin Emerg Drugs; 2016 Sep; 21(3):331-41. PubMed ID: 27347712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
    Jones ME
    Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newer beta-lactam antibiotics: doripenem, ceftobiprole, ceftaroline, and cefepime.
    Bazan JA; Martin SI; Kaye KM
    Infect Dis Clin North Am; 2009 Dec; 23(4):983-96, ix. PubMed ID: 19909894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent trend for the development of new antibacterial agents].
    Nishino T
    Nihon Rinsho; 2002 Nov; 60(11):2216-24. PubMed ID: 12440133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Has the era of untreatable infections arrived?
    Livermore DM
    J Antimicrob Chemother; 2009 Sep; 64 Suppl 1():i29-36. PubMed ID: 19675016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New agents in development for the treatment of bacterial infections.
    Abbanat D; Morrow B; Bush K
    Curr Opin Pharmacol; 2008 Oct; 8(5):582-92. PubMed ID: 18761107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in the development of beta-lactam antibiotics.
    Neu HC
    Scand J Infect Dis Suppl; 1984; 42():7-16. PubMed ID: 6597563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftaroline: a comprehensive update.
    Kaushik D; Rathi S; Jain A
    Int J Antimicrob Agents; 2011 May; 37(5):389-95. PubMed ID: 21420284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New β-lactam antibiotics and β-lactamase inhibitors.
    Bush K; Macielag MJ
    Expert Opin Ther Pat; 2010 Oct; 20(10):1277-93. PubMed ID: 20839927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.